Regulatory delays in UK collections deal
A large UK collections deal was delayed by a quarter due to regulatory approvals, impacting Q4 revenue. Though now live, similar delays could recur.
Firstsource Solutions · risk themes across the available quarters.
Bear-case history
A large UK collections deal was delayed by a quarter due to regulatory approvals, impacting Q4 revenue. Though now live, similar delays could recur.
Tighter regulatory environment for Medicare Advantage plans caused payers to pause program rollouts, creating a short-term timing impact on healthcare revenue.
Analyst questioned potential deflation from AI productivity; management acknowledged efficiency gains but argued TAM expansion offsets. Risk remains if outcome-based pricing scales slower.
CMT revenue declined 4% QoQ due to timing of work packets and program transitions in consumer tech; management expects normalization but volatility persists.